Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2014, Article ID 201705, 5 pages
http://dx.doi.org/10.1155/2014/201705
Research Article

Treatment Outcome of Tuberculosis Patients Registered at DOTS Centre in Ogbomoso, Southwestern Nigeria: A 4-Year Retrospective Study

1Department of Community Medicine, Ladoke Akintola University Teaching Hospital, Ogbomoso, Nigeria
2Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, UK
3Department of Medical Microbiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria

Received 13 May 2014; Accepted 5 August 2014; Published 28 September 2014

Academic Editor: Carlo Garzelli

Copyright © 2014 Olarewaju Sunday et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2010, World Health Organization, Geneva, Switzerland, 2010, (WHO/HTM/TB/2004.331); 2010 Contract No.: Document Number.
  2. WHO Global Tuberculosis Report 2009, 2009.
  3. E. L. Corbett, C. J. Watt, N. Walker et al., “The growing burden of tuberculosis: global trends and interactions with the HIV epidemic,” Archives of Internal Medicine, vol. 163, no. 9, pp. 1009–1021, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Dye, M. A. Espinal, C. J. Watt, C. Mbiaga, and B. G. Williams, “Worldwide incidence of multidrug-resistant tuberculosis,” Journal of Infectious Diseases, vol. 185, no. 8, pp. 1197–1202, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. T. R. Frieden, T. R. Sterling, S. S. Munsiff, C. J. Watt, and C. Dye, “Tuberculosis,” The Lancet, vol. 362, no. 9387, pp. 887–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. D. Mukadi and A. Harries, “Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa,” AIDS, vol. 15, no. 2, pp. 143–152, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. NTBLCP annual Report 2009.
  8. O. M. Ige, N. A. Bakare, and B. O. Onadeko, “Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria—a preliminary report,” African Journal of Medicine and Medical Sciences, vol. 29, no. 1, pp. 51–53, 2000. View at Google Scholar · View at Scopus
  9. G. E. Erhabor, O. Adewole, A. O. Adisa, and O. A. Olajolo, “Directly observed short course therapy for tuberculosis—a preliminary report of a three-year experience in a teaching hospital,” Journal of the National Medical Association, vol. 95, no. 11, pp. 1082–1088, 2003. View at Google Scholar · View at Scopus
  10. J. Veen, M. Raviglione, H. L. Rieder et al., “Standardized tuberculosis treatment outcome monitoring in Europe,” European Respiratory Journal, vol. 12, no. 2, pp. 505–510, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. Ministry of Health of Nigeria (MOH), Tuberculosis and Leprosy and Control Programme Workers Manual.
  12. M. Gninafon, L. Tawo, F. Kassa et al., “Outcome of tuberculosis retreatment in routine conditions in Cotonou, Benin,” International Journal of Tuberculosis and Lung Disease, vol. 8, no. 10, pp. 1242–1247, 2004. View at Google Scholar · View at Scopus
  13. E. Rutta, R. Kipingili, H. Lukonge, S. Assefa, E. Mitsilale, and S. Rwechungura, “Treatment outcome among Rwandan and Burundian refugees with sputum smear-positive tuberculosis in Ngara, Tanzania,” International Journal of Tuberculosis and Lung Disease, vol. 5, no. 7, pp. 628–632, 2001. View at Google Scholar · View at Scopus
  14. E.-S. Al Kah, D. A. Enarson, O. Baraka, S. A. Mustafa, and G. Bjune, “Treatment results of DOTS in 1797 sudanese tuberculosis patients wit h or without HIV co-infection,” International Journal of Tuberculosis and Lung Disease, vol. 6, no. 12, pp. 1058–1066, 2002. View at Google Scholar
  15. A. Kochi, “The global tuberculosis situation and the new control strategy of the World Health Organization,” Tubercle, vol. 72, no. 1, pp. 1–6, 1991. View at Publisher · View at Google Scholar · View at Scopus
  16. S. I. Cadmus, “Insight into the epidemiology of laboratory confirmed human tuberculosis in Ibadan, Nigeria,” African Journal of Medicine and Medical Sciences, vol. 39, pp. 213–218, 2010. View at Google Scholar · View at Scopus
  17. A. K. Salami and P. O. Oluboyo, “Hospital prevalence of pulmonary tuberculosis and co-infection with human immunodeficiency virus in Ilorin: a review of nine years (1991–1999),” West African Journal of Medicine, vol. 21, no. 1, pp. 24–27, 2002. View at Google Scholar · View at Scopus
  18. B. E. Egbewale, S. S. Taiwo, O. O. Odu, O. A. Olowu, and S. O. Sobaloju, “Tuberculosis treatment outcomes in State Hospital, Osogbo, Southwestern Nigeria: a 4 year review,” Nigerian Journal of Medicine, vol. 16, no. 2, pp. 148–154, 2007. View at Google Scholar · View at Scopus